June 30, 2020 / 5:26 AM / 6 days ago

BRIEF-Crispr Therapeutics Commencing Underwritten Public Offering Of $325 Mln Of Common Shares

June 30 (Reuters) - CRISPR Therapeutics AG:

* CRISPR THERAPEUTICS AG - COMMENCING AN UNDERWRITTEN PUBLIC OFFERING OF $325 MILLION OF COMMON SHARES

* UNDERWRITERS WILL HAVE A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL $48,750,000 OF COMMON SHARES AT THE PUBLIC OFFERING PRICE LESS THE UNDERWRITING DISCOUNT

* OFFERING WILL BE MADE ONLY BY MEANS OF A PROSPECTUS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below